CVS Health Corporation (CVS)

Market Cap	70.16B
Revenue (ttm)	360.94B
Net Income (ttm)	7.32B
Shares Out	1.26B
EPS (ttm)	5.70
PE Ratio	9.79
Forward PE	6.45
Dividend	$2.66 (4.76%)
Ex-Dividend Date	Apr 19, 2024

Volume	7,347,205
Open	56.21
Previous Close	56.00
Day's Range	55.69 - 56.49
52-Week Range	53.70 - 83.25
Beta	0.55
Analysts	Buy
Price Target	77.95 (+39.5%)
Earnings Date	May 1, 2024

About CVS

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers phar...

• Industry: Healthcare Plans
• Sector: Healthcare
• Founded: 1963
• Employees: 300,000
• Stock Exchange: NYSE
• Ticker Symbol: CVS

Financial Performance

In 2023, CVS Health's revenue was $357.78 billion, an increase of 10.95% compared to the previous year's $322.47 billion. Earnings were $8.34 billion, an increase of 93.55%.

Analyst Forecast

According to 20 analysts, the average rating for CVS stock is "Buy." The 12-month stock price forecast is $77.95, which is an increase of 39.50% from the latest price.

Price Target

$77.95

(39.50% upside)

Analyst Consensus: Buy